Page 85 - Annual Report
P. 85

HONG KONG ACADEMY OF MEDICINE
            香 港 醫 學 專 科 學 院
            香港醫學專科學院
            NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
            FOR THE YEAR ENDED 31 DECEMBER 2023



            2.   BASIS OF PREPARATION AND MATERIAL ACCOUNTING POLICY INFORMATION (Continued)

                 g)   Credit losses and impairment of assets (Continued)

                     (i)     Credit losses from financial instruments (Continued)

                           Write-off policy (Continued)

                           Subsequent recoveries of an asset that was previously written off are  recognised as a
                           reversal of impairment in profit or loss in the period in which the recovery occurs.

                     (ii)    Impairment of other non-current assets

                           Assets are tested for impairment whenever events or changes in circumstances indicate
                           that the carrying amount may not be recoverable.

                           Internal and external sources of information are reviewed at the end of each reporting
                           period to identify indications that plant and equipment including right-of-use assets may
                           be impaired or, an impairment loss previously recognised no longer exists or may have
                           decreased.

                           If any such indication exists, the asset’s recoverable amount is estimated:

                           –    Calculation of recoverable amount

                                The recoverable amount of an asset  is the greater of its fair value less costs of
                                disposal  and  value  in  use.  In  assessing  value  in  use,  the  estimated  future  cash
                                flows are discounted to their present value using a pre-tax discount rate that reflects
                                current market assessments of the time value of money and the risks specific to the
                                asset. Where an asset does not generate cash inflows largely independent of those
                                from other assets, the recoverable amount is determined for the smallest group of
                                assets that generates cash inflows independently (i.e. a cash-generating unit).

                           –    Recognition of impairment losses

                                An impairment loss is recognised in profit or loss if the carrying amount of an asset,
                                or the cash-generating unit to which it belongs, exceeds its recoverable amount.
                                Impairment losses recognised in respect of cash-generating units are allocated to
                                reduce the carrying amount of the assets in the unit (or group of units) on a pro rata
                                basis,  except  that  the  carrying  value  of  an  asset  will  not  be  reduced  below  its
                                individual  fair  value  less  costs  of  disposal  (if  measurable)  or  value  in  use  (if
                                determinable).

                           –    Reversals of impairment losses

                                An  impairment  loss  is  reversed  if  there  has  been  a  favourable  change  in  the
                                estimates used to determine the recoverable amount.

                                A reversal of an impairment loss is limited to the asset’s carrying amount that would
                                have  been  determined  had  no  impairment  loss  been  recognised  in  prior  years.
                                Reversals of impairment losses are credited to profit or loss in the year in which the
                                reversals are recognised.


 15                                                       16  16


                                                                                                                 83
                                                                                    香港醫學專科學院 2024 年度報告
   80   81   82   83   84   85   86   87   88   89   90